DILLON ADRIAN T

Average Profitability
21.82%
Insider Buys Quantity
6
Insider Buys Sum
$2.53M
Insider Sells Quantity
9
Insider Sells Sum
$45.78M

Insider Activity of DILLON ADRIAN T

The largest purchase of all time was on 2019-07-12 and amounted to 10000 shares of HealthEquity, Inc. for $610,000.

The largest sale of all time was on 2010-03-30 and amounted to 305130 shares of Agilent Technologies, Inc. for $10.38M.

Biography of DILLON ADRIAN T

No biography is available at this moment.

2021-12-14PurchaseHealthEquity, Inc.
HQY
director
12,375
0.015%
$40.47$500,811+54.37%
2019-07-12PurchaseHealthEquity, Inc.
HQY
director
10,000
0.0133%
$61.00$610,000-14.89%
2017-03-30PurchaseHealthEquity, Inc.
HQY
director
10,000
0.0166%
$40.53$405,273+19.74%
2015-06-10SaleWilliams-Sonoma, Inc.
WSM
director
8,776
0.0096%
$78.56$689,443-19.66%
2015-06-08SaleWilliams-Sonoma, Inc.
WSM
director
31,000
0.0341%
$78.78$2.44M-18.87%
2012-06-28PurchaseWilliams-Sonoma, Inc.
WSM
director
15,110
0.0151%
$33.14$500,706+37.55%
2011-10-06PurchaseWilliams-Sonoma, Inc.
WSM
director
7,200
0.0068%
$30.88$222,345+20.16%
2010-03-30SaleAgilent Technologies, Inc.
A
EVP, Finance & Admin., CFO
305,130
0.0862%
$34.02$10.38M+0.38%
2010-03-11SaleAgilent Technologies, Inc.
A
EVP, Finance & Admin., CFO
276,765
0.0722%
$30.48$8.43M+2.17%
2009-12-21SaleAgilent Technologies, Inc.
A
EVP, Finance & Admin., CFO
275,699
0.0755%
$28.49$7.85M+7.14%
2009-12-16SaleAgilent Technologies, Inc.
A
EVP, Finance & Admin., CFO
163,137
0.0456%
$28.96$4.72M+7.22%
2009-12-15SaleAgilent Technologies, Inc.
A
EVP, Finance & Admin., CFO
248,896
0.0718%
$30.02$7.47M+5.95%
2009-12-14SaleAgilent Technologies, Inc.
A
EVP, Finance & Admin., CFO
86,211.97
0.0235%
$28.38$2.45M+5.06%
2007-12-24SaleAgilent Technologies, Inc.
A
EVP, Finance & Admin., CFO
36,000
0.0097%
$36.93$1.33M-13.87%
2006-09-08PurchaseWilliams-Sonoma, Inc.
WSM
director
10,000
0.0089%
$29.50$294,986+13.96%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.